Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Narrative) (Details)

v3.23.3
Intangible Assets (Narrative) (Details) - USD ($)
3 Months Ended
Aug. 14, 2023
Sep. 30, 2023
Sep. 30, 2022
Aug. 23, 2021
Finite-Lived Intangible Assets [Line Items]        
Amortization of Intangible Assets   $ 5,000 $ 67,000  
Patents and Licenses [Member]        
Finite-Lived Intangible Assets [Line Items]        
Impairment of intangible assets $ 25,000 $ 565,000    
RubrYc Therapeutics Inc [Member] | Immune-Oncology Antibodies (RTX-003) [Member]        
Finite-Lived Intangible Assets [Line Items]        
Investment       $ 7,500,000